SlideShare a Scribd company logo
1 of 3
Download to read offline
pp893-895 BMSoct08      17/9/08     15:30    Page 893




         MICROBIOLOGY IN AFRICA                                                                                                          ARTICLE




        Antimicrobial testing
        for paediatric bacterial
        meningitis in Sudan
                                                                                                            facilities because a single dose of this
         Sudan lies within the so-called meningitis belt that stretches across Africa                       long-acting formulation has been shown
                                                                                                            to be effective.4
         from Senegal in the west to Ethiopia in the east. Here, Mahadi Mahmoud
                                                                                                            BUGS FROM BRAZIL
         and colleagues focus on this devastating bacterial infection in the paediatric                     The incidence of bacterial meningitis is
                                                                                                            higher in developing countries than in
         setting in Khartoum.                                                                               developed countries1–10 and is particularly
                                                                                                            high in children under one year old. Mortality
                                                                                                            rates for bacterial meningitis range from
        Bacterial meningitis is an inflammatory         are through direct contact with patients with       4.5% in developed countries to 15–50% in
        process of the meninges and is a major          meningococcal disease.3                             developing countries.5
        cause of death and disability worldwide.1          Of the other common pathogens that                   It has been proposed that clinical efficacy
        Meningococcal disease was first described       cause paediatric bacterial meningitis,              and safety of short-duration regimens of third-
        in 1805 when an outbreak occurred in            Haemophilus influenzae and Streptococcus            generation cephalosporin therapy (ie five days
        Geneva, Switzerland. However, the causative     pneumoniae are susceptible to penicillin and        versus seven days or five days versus 10 days
        agent, Neisseria meningitidis, was not          cefotaxime.1 A range of antibiotics may be          of cefotaxime or ceftriaxone) for bacterial
        identified until 1887. Twelve serogroups        used for treatment, including penicillin,           meningitis should be studied.6,7 In Brazil,
        of N. meningitidis have been identified and     ampicillin, chloramphenicol and ceftriaxone.        antimicrobial susceptibility has been
        four (N. meningitidis A, B, C and W 135)        In epidemics, oily chloramphenicol is the           determined for 150 H. influenzae isolates
        have caused epidemics.2                         drug of choice in areas with limited health         obtained during population-based surveillance
            N. meningitidis is a Gram-negative
        diplococcus (Fig 1) that possesses capsular
        polysaccharide antigens that differentiate
        eight serogroups (A, B, C, X, Y, Z, 29-E and
        W135). Subtyping identifies certain strains
        that are associated with increased virulence
        and epidemic potential. The organism can
        grow on blood agar and produces haemolytic
        colonies. Most cases of N. meningitidis
        infection are acquired through exposure to
        asymptomatic carriers, while relatively few

            ‘The incidence of bacterial
            meningitis is higher in
            developing countries than in
            developed countries and is
            particularly high in children
            under one year old’                          Fig 1. Intracellular meningococci in a cerebrospinal fluid sample.


         OCTOBER 2008                                                                                        THE BIOMEDICAL SCIENTIST                  893
pp893-895 BMSoct08      17/9/08      15:31     Page 894




         ARTICLE

        for meningitis, and 10 (6.7%) isolates were
        resistant to ampicillin and chloramphenicol.               600
        Of these, two isolates, a β-lactamase and                  500                                                                        Cases 2000
        non-β-lactamase producer, were resistant to                                                                                           Cases 2001
        amoxacillin-clavulanic acid. These findings                400                                                                        Cases 2002




                                                           Cases
        indicate that present antibiotic regimens in               300
        Brazil may not be appropriate for the
                                                                   200
        treatment of H. influenzae meningitis.8
                                                                   100
        PENETRATING THE
                                                                     0
        CEREBROSPINAL SPACE
                                                                         1   3   5   7   9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 41 43 45 47 49 51
        Either parenteral penicillin or ampicillin is
        the drug of choice, while chloramphenicol is a                                                          Weeks
        good and inexpensive alternative.9 The third-
        generation cephalosporins ceftriaxone and          Fig 2. Meningitis cases reported in Sudan (2000–2002).
        cefotaxime are excellent alternatives but are
        considerably more expensive. On the other             Prevalence of paediatric bacterial                        ‘Other common pathogens
        hand, ceftriaxone can be administered once a      meningitis in the population studied was
        day for as short a period as just two days,       20.4%, and the most common isolated                           that cause paediatric
        which needs to be taken into account when         organism was N. meningitidis (78.8%),
        comparing the total costs of treatment with       followed by H. influenzae (16.4%). The latter                 bacterial meningitis include
        this antibiotic.10                                is a common causative agent of paediatric
            Worldwide, one million cases of bacterial     meningitis in similar studies carried out in                  Haemophilus influenzae and
        meningitis are estimated to occur and             the USA, Wales, Australia and Israel, with
        200,000 of these are fatal. Meningitis remains    H. influenzae isolation rates of 40% , 22%,                   Streptococcus pneumoniae’
        a major public health challenge in the            25% and 18%, respectively.16 Other similar
        African ‘meningitis belt’, an area that extends   studies have shown H. influenzae rates of
        from Senegal to Ethiopia with an estimated        23.8% and 33.8%.17                                       sulphonate and chloramphenicol resistance
        total population of 300 million. Over the last        The isolation rate for S. pneumoniae of              was 40% and 13, respectively.
        10 years some 700,000 cases of epidemic           5.5% in the present study was low compared
        meningitis have been reported, and about          with other reported rates of 14.3% and 14.8%             ACTIVE SURVEILLANCE
        10% of patients have died.11                      (from Saudi Arabia), and with rates in                   Most of the isolates show a pattern of resistant
            Epidemics in the meningitis belt have been    non-meningitis belt countries of 30–50%                  for most of the commonly used antibiotics,
        associated traditionally with serogroup A N.      and 25–35%, and N. meningitidis rates                    which suggests a high rate of misuse of these
        meningitidis. In Sudan, many outbreaks have       of 25–35%.18–20 Surveillance in Egypt                    agents. Moreover, the lack of laboratory
        occurred over the past years,12 as shown in the   (1998–2002)21 shows similar findings to                  facilities to establish proper isolation,
        chart covering the years 2000–2002 (Fig 2).       those reported here, with H. influenzae                  identification and susceptibility testing to
            All humans are susceptible to meningitis,     rates of 18%; however, infection rate for                facilitate diagnosis is a contributing factor.
        which has an incubation period that varies        S. pneumoniae was high at 37% but for                        Establishment of a treatment strategy
        from one to 10 days (usually <4 days).            N. meningitidis was low at 17%.                          for bacterial meningococcal infection is
        Many antimicrobials are active against                N. meningitidis showed a pattern                     required. Surveillance and a vaccination
        meningococci in vitro, but only those that        of resistance to erythromycin (36.4%),                   programme should be activated in epidemic
        penetrate the cerebrospinal space should          chloramphenicol (20.5%), trimethoprim                    areas, especially for children, and the
        be used.13                                        sulphonate (11.4%) and ceftriaxone (4.7%).               development of molecular techniques to
                                                          However, these results differed from those               detect resistant strains would be helpful.
        SEROTYPING TO SUSCEPTABILITY                      of a similar study performed in Saudi Arabia,            Finally, health education is essential through
        This study from Sudan aims to evaluate the        which shows resistance to chloramphenicol                public awareness of meningitis, and also
        common causative agents of bacterial              at 12.7%, and a Kenyan study that shows                  an understanding that antimicrobial agents
        meningitis in this area of Africa among a         resistance at 8%.                                        often are misused.                             ᔢ
        paediatric population, and to study the               H. influenzae was resistant to most
        pattern of antimicrobial susceptibility testing   commonly used antimicrobial agent (ampicillin            REFERENCES
        in Khartoum state.                                45.5%, chloramphenicol 27.3%, ceftriaxone                1 Greenwood D, Slack RCB, Peutherer JF.
            Samples of cerebrospinal fluid (CSF; 1        9.1%, rifampin 54.5%), while S. pneumoniae                 Medical microbiology. A guide to
        mL) were put in a vial of T-I medium, using a     showed no resistance to chloramphenicol and                microbiological infections: pathogenesis,
        sterile technique.14 Gram stain was performed     trimethoprim sulphonate, but some resistance               immunity, laboratory diagnosis and
        and culture was carried out in GC medium          to vancomycin (33%), oxacillin (66.7%) and                 control 16th edn. Edinburgh: Churchill
        on blood agar. Identification, serotyping and     erythromycin (66.7%). This is comparable with              Livingstone, 1997.
        susceptibility testing were all performed         the Egyptian results,21 although trimethoprim            2 Quagliarello VJ, Scheld WM. Treatment of
        according to the World Health Organization                                                                   bacterial meningitis. N Engl J Med 1997;
        (WHO SOPS-2005) strategy.15                                                                                  336: 708–16.
            A total of 59 organisms were isolated                  ‘Studies suggest that                           3 Wenger JD, Hightower AW, Facklam RR,
        from 284 CSF samples from children with                                                                      Gaventa S, Broome CV. Bacterial
        suspected meningitis. Of the 59 organisms                  current antibiotic regimens                       meningitis in the United States, 1986:
        identified, 44 were N. meningitidis,                                                                         report of a multistate surveillance study.
        12 were H. influenzae and just three were                  in Brazil may not be                              The Bacterial Meningitis Study Group.
        S. pneumoniae. Distribution by gender                                                                        J Infect Dis 1990; 162: 1316–23.
        showed the following: N. meningitidis (male                appropriate for the treatment                   4 World Health Organization and the
        24, female 20), H. influenzae (male 7, female                                                                Centers for Disease Control and
        3) and S. pneumoniae (male 2, female 1).                   of H. influenzae meningitis’                      Prevention. Technical guidelines for


         894              THE BIOMEDICAL SCIENTIST                                                                                              OCTOBER 2008
pp879-885 BMSoct08      17/9/08                                          15:26    Page 885




                                                                                                                                                                                  ARTICLE

        22 Borghouts C, Scheckhuber CQ, Stephan                                                  deletion in vivo in normal human skin.              36 Onyango P Celic I, McCaffery JM, Boeke
                                                                                                                                                                    ,
           O, Osiewacz HD. Copper homeostasis                                                    J Invest Dermatol 2004; 122: 1277–83.                  JD, Feinberg AP SIRT3, a human SIR2
                                                                                                                                                                        .
           and aging in the fungal model system                                               29 Brunk UT, Terman A. The mitochondrial-                 homologue, is an NAD-dependent
           Podospora anserina: differential                                                      lysosomal axis theory of aging:                        deacetylase localized to mitochondria.
           expression of PaCtr3 encoding a copper                                                accumulation of damaged mitochondria                   Proc Natl Acad Sci USA 2002; 99:
           transporter. Int J Biochem Cell Biol 2002;                                            as a result of imperfect autophagocytosis.             13653–8.
           34 (11): 1355–71.                                                                     Eur J Biochem 2002; 269 (8): 1996–2002.             37 Schwer B, North BJ, Frye RA, Ott M,
        23 Brookes PS, Land JM, Clark JB, Heales                                              30 Guarente L. Mitochondria – a nexus for                 Verdin E. The human silent information
           SJR. Peroxynitrite and brain mitochondria:                                            aging, calorie restriction and sirtuins? Cell          regulator (Sir)2 homologue hSIRT3 is a
           evidence for increased proton leak. J                                                 2008; 132 (2): 171–6.                                  mitochondrial nicotinamide adenine
           Neurochem 1998; 70 (5): 2195–202.                                                  31 Ku HH, Brunk UT, Sohal RS. Relationship                dinucleotide-dependent deacetylase.
        24 Delaval E, Perichon M, Friguet B. Age-                                                between mitochondrial superoxide and                   J Cell Biol 2002; 158: 647–57.
           related impairment of mitochondrial                                                   hydrogen peroxide production and                    38 Bellizzi D, Rose G, Cavalcante P et al.
           matrix aconitase and ATP-stimulated                                                   longevity of mammalian species. Free Rad               A novel VNTR enhancer within the SIRT3
           protease in rat liver and heart. Eur J                                                Biol Med 1993; 15 (6): 621–7.                          gene, a human homologue of SIR2, is
           Biochem 2004; 271 (22): 4559–64.                                                   32 Barja G, Herrero A. Oxidative damage to                associated with survival at oldest ages.
        25 de Grey A. Reactive oxygen species                                                    mitochiondrial DNA is inversely related                Genomics 2005; 85: 258–63.
           production in the mitochondrial matrix:                                               to maximum life span in the heart and               39 Hallows WC, Lee S, Denu JM. Sirtuins
           implications for the mechanism of                                                     brains of mammals. FASEB J 2000;                       deacetylate and activate mammalian
           mitochondrial mutation accumulation.                                                  14: 312–8.                                             acetyl-CoA synthetases. Proc Natl Acad
           Rejuvenation Res 2005; 8 (1): 13–7.                                                33 Haigis MC, Guarente LP Mammalian
                                                                                                                           .                            Sci USA 2006; 103: 10230–5.
        26 Kujoth GC, Bradshaw PC, Haroon S,                                                     sirtuins – emerging roles in physiology,            40 Schwer B, Bunkenborg J, Verdin RO,
           Prolla TA. The role of mitochondrial DNA                                              aging, and calorie restriction Genes Dev               Andersen JS, Verdin E. Reversible lysine
           mutations in mammalian aging. PLoS                                                    2006; 20 (21): 2913–21.                                acetylation controls the activity of the
           Genet 2007; 3 (2): e24.                                                            34 Civitarese AE, Carling S, Heilbronn LK et              mitochondrial enzyme acetyl-CoA
        27 Wang Y, Michikawa Y, Mallidis C et al.                                                al. Calorie restriction increases muscle               synthetase 2. Proc Natl Acad Sci USA
           Muscle-specific mutations accumulate                                                  mitochondrial biogenesis in healthy                    2006; 103: 10224–9.
           with aging in critical human mtDNA                                                    humans. PLoS Med 2007; 4 (3): e76.
           control sites for replication. Proc Natl Acad                                      35 Scher MB, Vaquero A, Reinberg D. SirT3
                                                                                                                                                      Dr Isabelle Imbert, Anne-Francoise Clay, Joel
           Sci USA 2001; 98: 4022–7.                                                             is a nuclear NAD+-dependent histone
                                                                                                                                                      Mantelin and Dr Karine Cucumel are
        28 Berneburg M, Plettenberg H, Medve-König                                               deacetylase that translocates to the
                                                                                                                                                      research scientists at Vincience, ISP Global
           K et al. Induction of the photoaging-                                                 mitochondria upon cellular stress. Genes
                                                                                                                                                      Skin Research Centre, France.
           associated mitochondrial common                                                       Dev 2007; 21: 920–8.
          BJBS



                                                                            A selection of topics
                                                                            in Volume 65,
                                                                            Number 4, 2008
                                                                          • Comparative in vitro antimicrobial procedural efficacy for susceptibility
                                                                            of Staphylococcus aureus, Escherichia coli and Pseudomonas species
                                                                            to chloramphenicol, ciprofloxacin and cefaclor
                                                                          • Correlation of Bmi-1 expression and telomerase activity in human
                                                                            ovarian cancer
                               Available online at www.bjbs-online.org




                                                                          • Effect of cytokines on hyaluronan synthase activity and response
                                                                            to oxidative stress by fibroblasts
                                                                          • Molecular characterisation of the recA locus in clinical isolates                Reading a
                                                                            of verocytotoxigenic E. coli O157:H7                                             colleague’s
                                                                          • Cloning and structural analysis of full-length cytolethal distending             copy of
                                                                            toxin (cdt) gene operon from Campylobacter lari
                                                                          • Reduction of Staphylococcus epidermidis adhesion to indwelling
                                                                                                                                                             The Biomedical
                                                                            medical devices: a simple procedure                                              Scientist?
                                                                          • Antibiotic susceptibility patterns of Helicobacter pylori strains from           Join the IBMS
                                                                            patients with upper gastrointestinal pathology in western Nigeria
                                                                                                                                                             and its CPD
                                                                          • Fluorescence (FISH) and chromogenic (CISH) in situ hybridisation in
                                                                            prostate carcinoma cell lines: comparison and use of virtual microscopy          scheme
                                                                          • Good analytical practice: statistics and handling data in the biomedical         Keep in touch with
                                                                            sciences. A primer and directions for authors. Part 1: Introduction.             your profession and
                                                                            Data within and between one or two sets of individuals
                                                                                                                                                             update your skills



         OCTOBER 2008                                                                                                                                 THE BIOMEDICAL SCIENTIST                 885

More Related Content

What's hot (18)

Epstein-Barr Virus
Epstein-Barr Virus�Epstein-Barr Virus�
Epstein-Barr Virus
 
Pox virus
Pox virusPox virus
Pox virus
 
Vaccines by Dr.Jayshree Nellore
Vaccines by Dr.Jayshree NelloreVaccines by Dr.Jayshree Nellore
Vaccines by Dr.Jayshree Nellore
 
Parvo virus
Parvo virusParvo virus
Parvo virus
 
Human Clinical and Veterinary Parasitology
Human Clinical and Veterinary ParasitologyHuman Clinical and Veterinary Parasitology
Human Clinical and Veterinary Parasitology
 
Tuberculosis
TuberculosisTuberculosis
Tuberculosis
 
Epstein barr virus
Epstein barr virus Epstein barr virus
Epstein barr virus
 
Epstein barr virus
Epstein barr virusEpstein barr virus
Epstein barr virus
 
Viral skin-diseases
Viral skin-diseasesViral skin-diseases
Viral skin-diseases
 
GBS in early ife
GBS in early ifeGBS in early ife
GBS in early ife
 
Presentation On Buruli Ulcer
Presentation On Buruli UlcerPresentation On Buruli Ulcer
Presentation On Buruli Ulcer
 
Influenza virus-characterisation-march-2016
Influenza virus-characterisation-march-2016Influenza virus-characterisation-march-2016
Influenza virus-characterisation-march-2016
 
Vaccinology
Vaccinology Vaccinology
Vaccinology
 
Derma.
Derma.Derma.
Derma.
 
Biochemistry of herpes viruses
Biochemistry of herpes virusesBiochemistry of herpes viruses
Biochemistry of herpes viruses
 
Immune response and vaccines of Poliovirus- Respuesta Inmune y vacunas durant...
Immune response and vaccines of Poliovirus- Respuesta Inmune y vacunas durant...Immune response and vaccines of Poliovirus- Respuesta Inmune y vacunas durant...
Immune response and vaccines of Poliovirus- Respuesta Inmune y vacunas durant...
 
Diagnostic Approaches to Chronic Fungal and Tuberculous Meningitis
Diagnostic Approaches to Chronic Fungal and Tuberculous MeningitisDiagnostic Approaches to Chronic Fungal and Tuberculous Meningitis
Diagnostic Approaches to Chronic Fungal and Tuberculous Meningitis
 
Vaccines herd immunity anti vaccine movt
Vaccines herd immunity anti vaccine movtVaccines herd immunity anti vaccine movt
Vaccines herd immunity anti vaccine movt
 

Similar to Meningitis in sudan

Seminar pmr726-meningitis and smallpox vaccine
Seminar pmr726-meningitis and smallpox vaccineSeminar pmr726-meningitis and smallpox vaccine
Seminar pmr726-meningitis and smallpox vaccineFarhan Furreh
 
Bacteria Isolated From the Cerebrio-Spinal Fluid (Csf) of Suspected Cases of ...
Bacteria Isolated From the Cerebrio-Spinal Fluid (Csf) of Suspected Cases of ...Bacteria Isolated From the Cerebrio-Spinal Fluid (Csf) of Suspected Cases of ...
Bacteria Isolated From the Cerebrio-Spinal Fluid (Csf) of Suspected Cases of ...iosrjce
 
Meningococcal meningitis
Meningococcal meningitisMeningococcal meningitis
Meningococcal meningitisamitakashyap1
 
Community Acquired Pneumonia (CAP) in Children Presentation Prepared by MrMWSK
Community Acquired   Pneumonia (CAP) in Children Presentation Prepared by MrMWSKCommunity Acquired   Pneumonia (CAP) in Children Presentation Prepared by MrMWSK
Community Acquired Pneumonia (CAP) in Children Presentation Prepared by MrMWSKMrMWSK .
 
Biotechnology product - Prevnar
Biotechnology product - PrevnarBiotechnology product - Prevnar
Biotechnology product - Prevnarnehagandhi68
 
N Meningitidis(Kim)
N Meningitidis(Kim)N Meningitidis(Kim)
N Meningitidis(Kim)guest045334
 
Timm athens candidaemia 2009
Timm athens candidaemia 2009Timm athens candidaemia 2009
Timm athens candidaemia 2009fungalinfection
 
Rising Enemy fungal in middle east clinical patho.pdf
Rising Enemy   fungal in middle east   clinical patho.pdfRising Enemy   fungal in middle east   clinical patho.pdf
Rising Enemy fungal in middle east clinical patho.pdfEmad Zarief Kamel
 
Atypical pneumonia
Atypical pneumoniaAtypical pneumonia
Atypical pneumoniamazin malik
 
Bacterial Meningitis in Paediatrics A Review.pdf
Bacterial Meningitis in Paediatrics A Review.pdfBacterial Meningitis in Paediatrics A Review.pdf
Bacterial Meningitis in Paediatrics A Review.pdfPUBLISHERJOURNAL
 
Paedantifungalguidelines(drug choices)
Paedantifungalguidelines(drug choices)Paedantifungalguidelines(drug choices)
Paedantifungalguidelines(drug choices)fungalinfection
 
Chlamydia Conjunctivitis
Chlamydia Conjunctivitis Chlamydia Conjunctivitis
Chlamydia Conjunctivitis Amr Mounir
 
Tuberculosis new.pptx
Tuberculosis new.pptxTuberculosis new.pptx
Tuberculosis new.pptxssuseref3feb
 
Orthomyxoviruses & Paramyxoviruses, Influenza, Measles & Mumps.
Orthomyxoviruses & Paramyxoviruses, Influenza, Measles & Mumps. Orthomyxoviruses & Paramyxoviruses, Influenza, Measles & Mumps.
Orthomyxoviruses & Paramyxoviruses, Influenza, Measles & Mumps. Eneutron
 
Lecture 11. meningitis
Lecture 11. meningitisLecture 11. meningitis
Lecture 11. meningitisVasyl Sorokhan
 

Similar to Meningitis in sudan (20)

Seminar pmr726-meningitis and smallpox vaccine
Seminar pmr726-meningitis and smallpox vaccineSeminar pmr726-meningitis and smallpox vaccine
Seminar pmr726-meningitis and smallpox vaccine
 
Bacteria Isolated From the Cerebrio-Spinal Fluid (Csf) of Suspected Cases of ...
Bacteria Isolated From the Cerebrio-Spinal Fluid (Csf) of Suspected Cases of ...Bacteria Isolated From the Cerebrio-Spinal Fluid (Csf) of Suspected Cases of ...
Bacteria Isolated From the Cerebrio-Spinal Fluid (Csf) of Suspected Cases of ...
 
Meningococcal meningitis
Meningococcal meningitisMeningococcal meningitis
Meningococcal meningitis
 
Meningitis
Meningitis Meningitis
Meningitis
 
Community Acquired Pneumonia (CAP) in Children Presentation Prepared by MrMWSK
Community Acquired   Pneumonia (CAP) in Children Presentation Prepared by MrMWSKCommunity Acquired   Pneumonia (CAP) in Children Presentation Prepared by MrMWSK
Community Acquired Pneumonia (CAP) in Children Presentation Prepared by MrMWSK
 
Biotechnology product - Prevnar
Biotechnology product - PrevnarBiotechnology product - Prevnar
Biotechnology product - Prevnar
 
N Meningitidis(Kim)
N Meningitidis(Kim)N Meningitidis(Kim)
N Meningitidis(Kim)
 
FINAL MENINGITIS.pptx
FINAL MENINGITIS.pptxFINAL MENINGITIS.pptx
FINAL MENINGITIS.pptx
 
Need of new vaccine
Need of new vaccineNeed of new vaccine
Need of new vaccine
 
Timm athens candidaemia 2009
Timm athens candidaemia 2009Timm athens candidaemia 2009
Timm athens candidaemia 2009
 
Rising Enemy fungal in middle east clinical patho.pdf
Rising Enemy   fungal in middle east   clinical patho.pdfRising Enemy   fungal in middle east   clinical patho.pdf
Rising Enemy fungal in middle east clinical patho.pdf
 
Atypical pneumonia
Atypical pneumoniaAtypical pneumonia
Atypical pneumonia
 
Bacterial Meningitis in Paediatrics A Review.pdf
Bacterial Meningitis in Paediatrics A Review.pdfBacterial Meningitis in Paediatrics A Review.pdf
Bacterial Meningitis in Paediatrics A Review.pdf
 
#StaySafe: Alert Points for Meningococcal Meningitis
#StaySafe: Alert Points for Meningococcal Meningitis#StaySafe: Alert Points for Meningococcal Meningitis
#StaySafe: Alert Points for Meningococcal Meningitis
 
Paedantifungalguidelines(drug choices)
Paedantifungalguidelines(drug choices)Paedantifungalguidelines(drug choices)
Paedantifungalguidelines(drug choices)
 
Measles james
Measles  jamesMeasles  james
Measles james
 
Chlamydia Conjunctivitis
Chlamydia Conjunctivitis Chlamydia Conjunctivitis
Chlamydia Conjunctivitis
 
Tuberculosis new.pptx
Tuberculosis new.pptxTuberculosis new.pptx
Tuberculosis new.pptx
 
Orthomyxoviruses & Paramyxoviruses, Influenza, Measles & Mumps.
Orthomyxoviruses & Paramyxoviruses, Influenza, Measles & Mumps. Orthomyxoviruses & Paramyxoviruses, Influenza, Measles & Mumps.
Orthomyxoviruses & Paramyxoviruses, Influenza, Measles & Mumps.
 
Lecture 11. meningitis
Lecture 11. meningitisLecture 11. meningitis
Lecture 11. meningitis
 

More from Mahadi Hassan Mahmoud Abdallah

3. Sexually transmitted diseases (st ds) Dr. Mahadi Hassan
3. Sexually transmitted diseases (st ds) Dr. Mahadi Hassan3. Sexually transmitted diseases (st ds) Dr. Mahadi Hassan
3. Sexually transmitted diseases (st ds) Dr. Mahadi HassanMahadi Hassan Mahmoud Abdallah
 

More from Mahadi Hassan Mahmoud Abdallah (20)

Body fluid.Dr.Mahadi
Body fluid.Dr.Mahadi Body fluid.Dr.Mahadi
Body fluid.Dr.Mahadi
 
Wound infection ppt Dr.Mahadi
Wound infection ppt Dr.MahadiWound infection ppt Dr.Mahadi
Wound infection ppt Dr.Mahadi
 
Meningitis Dr. Mahadi
Meningitis Dr. MahadiMeningitis Dr. Mahadi
Meningitis Dr. Mahadi
 
Bacteriaemia and septicaemia dr. Mahadi
Bacteriaemia and septicaemia  dr. MahadiBacteriaemia and septicaemia  dr. Mahadi
Bacteriaemia and septicaemia dr. Mahadi
 
Klebsiella Dr. Mahadi ppt
Klebsiella Dr. Mahadi pptKlebsiella Dr. Mahadi ppt
Klebsiella Dr. Mahadi ppt
 
.Shigella Dr. mahadi ppt
.Shigella Dr. mahadi ppt.Shigella Dr. mahadi ppt
.Shigella Dr. mahadi ppt
 
E.coli Dr. Mahadi
E.coli Dr. Mahadi E.coli Dr. Mahadi
E.coli Dr. Mahadi
 
Antimicrobia agents dr. Mahadi
Antimicrobia agents dr. MahadiAntimicrobia agents dr. Mahadi
Antimicrobia agents dr. Mahadi
 
5. diarheal diseases of E.coli Dr. Mahadi H Abdallah
5. diarheal diseases of E.coli  Dr. Mahadi  H  Abdallah5. diarheal diseases of E.coli  Dr. Mahadi  H  Abdallah
5. diarheal diseases of E.coli Dr. Mahadi H Abdallah
 
Food poisoning by Dr. Mahadi H Abdallah
Food poisoning by Dr. Mahadi H AbdallahFood poisoning by Dr. Mahadi H Abdallah
Food poisoning by Dr. Mahadi H Abdallah
 
GIT by Dr. Mahadi H Abdallah
GIT by Dr. Mahadi H AbdallahGIT by Dr. Mahadi H Abdallah
GIT by Dr. Mahadi H Abdallah
 
4. GIT Dr.Mahadi
4. GIT  Dr.Mahadi4. GIT  Dr.Mahadi
4. GIT Dr.Mahadi
 
3. Sexually transmitted diseases (st ds) Dr. Mahadi Hassan
3. Sexually transmitted diseases (st ds) Dr. Mahadi Hassan3. Sexually transmitted diseases (st ds) Dr. Mahadi Hassan
3. Sexually transmitted diseases (st ds) Dr. Mahadi Hassan
 
2. genital tract infection GTI Dr. Mahadi
2. genital tract infection GTI Dr. Mahadi2. genital tract infection GTI Dr. Mahadi
2. genital tract infection GTI Dr. Mahadi
 
Urinary Tract Infection Dr.Mahadi H Abdallah
Urinary Tract Infection  Dr.Mahadi H AbdallahUrinary Tract Infection  Dr.Mahadi H Abdallah
Urinary Tract Infection Dr.Mahadi H Abdallah
 
2. genital tract infection &amp; sexual [last]
2. genital tract infection &amp; sexual [last]2. genital tract infection &amp; sexual [last]
2. genital tract infection &amp; sexual [last]
 
1. urinary tract infection (UTI)
1. urinary tract infection (UTI)1. urinary tract infection (UTI)
1. urinary tract infection (UTI)
 
Proteus mahadi ppt
Proteus mahadi pptProteus mahadi ppt
Proteus mahadi ppt
 
Pseudomonas mahadippt
Pseudomonas mahadipptPseudomonas mahadippt
Pseudomonas mahadippt
 
Shigella mahadi ppt
Shigella mahadi pptShigella mahadi ppt
Shigella mahadi ppt
 

Meningitis in sudan

  • 1. pp893-895 BMSoct08 17/9/08 15:30 Page 893 MICROBIOLOGY IN AFRICA ARTICLE Antimicrobial testing for paediatric bacterial meningitis in Sudan facilities because a single dose of this Sudan lies within the so-called meningitis belt that stretches across Africa long-acting formulation has been shown to be effective.4 from Senegal in the west to Ethiopia in the east. Here, Mahadi Mahmoud BUGS FROM BRAZIL and colleagues focus on this devastating bacterial infection in the paediatric The incidence of bacterial meningitis is higher in developing countries than in setting in Khartoum. developed countries1–10 and is particularly high in children under one year old. Mortality rates for bacterial meningitis range from Bacterial meningitis is an inflammatory are through direct contact with patients with 4.5% in developed countries to 15–50% in process of the meninges and is a major meningococcal disease.3 developing countries.5 cause of death and disability worldwide.1 Of the other common pathogens that It has been proposed that clinical efficacy Meningococcal disease was first described cause paediatric bacterial meningitis, and safety of short-duration regimens of third- in 1805 when an outbreak occurred in Haemophilus influenzae and Streptococcus generation cephalosporin therapy (ie five days Geneva, Switzerland. However, the causative pneumoniae are susceptible to penicillin and versus seven days or five days versus 10 days agent, Neisseria meningitidis, was not cefotaxime.1 A range of antibiotics may be of cefotaxime or ceftriaxone) for bacterial identified until 1887. Twelve serogroups used for treatment, including penicillin, meningitis should be studied.6,7 In Brazil, of N. meningitidis have been identified and ampicillin, chloramphenicol and ceftriaxone. antimicrobial susceptibility has been four (N. meningitidis A, B, C and W 135) In epidemics, oily chloramphenicol is the determined for 150 H. influenzae isolates have caused epidemics.2 drug of choice in areas with limited health obtained during population-based surveillance N. meningitidis is a Gram-negative diplococcus (Fig 1) that possesses capsular polysaccharide antigens that differentiate eight serogroups (A, B, C, X, Y, Z, 29-E and W135). Subtyping identifies certain strains that are associated with increased virulence and epidemic potential. The organism can grow on blood agar and produces haemolytic colonies. Most cases of N. meningitidis infection are acquired through exposure to asymptomatic carriers, while relatively few ‘The incidence of bacterial meningitis is higher in developing countries than in developed countries and is particularly high in children under one year old’ Fig 1. Intracellular meningococci in a cerebrospinal fluid sample. OCTOBER 2008 THE BIOMEDICAL SCIENTIST 893
  • 2. pp893-895 BMSoct08 17/9/08 15:31 Page 894 ARTICLE for meningitis, and 10 (6.7%) isolates were resistant to ampicillin and chloramphenicol. 600 Of these, two isolates, a β-lactamase and 500 Cases 2000 non-β-lactamase producer, were resistant to Cases 2001 amoxacillin-clavulanic acid. These findings 400 Cases 2002 Cases indicate that present antibiotic regimens in 300 Brazil may not be appropriate for the 200 treatment of H. influenzae meningitis.8 100 PENETRATING THE 0 CEREBROSPINAL SPACE 1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 41 43 45 47 49 51 Either parenteral penicillin or ampicillin is the drug of choice, while chloramphenicol is a Weeks good and inexpensive alternative.9 The third- generation cephalosporins ceftriaxone and Fig 2. Meningitis cases reported in Sudan (2000–2002). cefotaxime are excellent alternatives but are considerably more expensive. On the other Prevalence of paediatric bacterial ‘Other common pathogens hand, ceftriaxone can be administered once a meningitis in the population studied was day for as short a period as just two days, 20.4%, and the most common isolated that cause paediatric which needs to be taken into account when organism was N. meningitidis (78.8%), comparing the total costs of treatment with followed by H. influenzae (16.4%). The latter bacterial meningitis include this antibiotic.10 is a common causative agent of paediatric Worldwide, one million cases of bacterial meningitis in similar studies carried out in Haemophilus influenzae and meningitis are estimated to occur and the USA, Wales, Australia and Israel, with 200,000 of these are fatal. Meningitis remains H. influenzae isolation rates of 40% , 22%, Streptococcus pneumoniae’ a major public health challenge in the 25% and 18%, respectively.16 Other similar African ‘meningitis belt’, an area that extends studies have shown H. influenzae rates of from Senegal to Ethiopia with an estimated 23.8% and 33.8%.17 sulphonate and chloramphenicol resistance total population of 300 million. Over the last The isolation rate for S. pneumoniae of was 40% and 13, respectively. 10 years some 700,000 cases of epidemic 5.5% in the present study was low compared meningitis have been reported, and about with other reported rates of 14.3% and 14.8% ACTIVE SURVEILLANCE 10% of patients have died.11 (from Saudi Arabia), and with rates in Most of the isolates show a pattern of resistant Epidemics in the meningitis belt have been non-meningitis belt countries of 30–50% for most of the commonly used antibiotics, associated traditionally with serogroup A N. and 25–35%, and N. meningitidis rates which suggests a high rate of misuse of these meningitidis. In Sudan, many outbreaks have of 25–35%.18–20 Surveillance in Egypt agents. Moreover, the lack of laboratory occurred over the past years,12 as shown in the (1998–2002)21 shows similar findings to facilities to establish proper isolation, chart covering the years 2000–2002 (Fig 2). those reported here, with H. influenzae identification and susceptibility testing to All humans are susceptible to meningitis, rates of 18%; however, infection rate for facilitate diagnosis is a contributing factor. which has an incubation period that varies S. pneumoniae was high at 37% but for Establishment of a treatment strategy from one to 10 days (usually <4 days). N. meningitidis was low at 17%. for bacterial meningococcal infection is Many antimicrobials are active against N. meningitidis showed a pattern required. Surveillance and a vaccination meningococci in vitro, but only those that of resistance to erythromycin (36.4%), programme should be activated in epidemic penetrate the cerebrospinal space should chloramphenicol (20.5%), trimethoprim areas, especially for children, and the be used.13 sulphonate (11.4%) and ceftriaxone (4.7%). development of molecular techniques to However, these results differed from those detect resistant strains would be helpful. SEROTYPING TO SUSCEPTABILITY of a similar study performed in Saudi Arabia, Finally, health education is essential through This study from Sudan aims to evaluate the which shows resistance to chloramphenicol public awareness of meningitis, and also common causative agents of bacterial at 12.7%, and a Kenyan study that shows an understanding that antimicrobial agents meningitis in this area of Africa among a resistance at 8%. often are misused. ᔢ paediatric population, and to study the H. influenzae was resistant to most pattern of antimicrobial susceptibility testing commonly used antimicrobial agent (ampicillin REFERENCES in Khartoum state. 45.5%, chloramphenicol 27.3%, ceftriaxone 1 Greenwood D, Slack RCB, Peutherer JF. Samples of cerebrospinal fluid (CSF; 1 9.1%, rifampin 54.5%), while S. pneumoniae Medical microbiology. A guide to mL) were put in a vial of T-I medium, using a showed no resistance to chloramphenicol and microbiological infections: pathogenesis, sterile technique.14 Gram stain was performed trimethoprim sulphonate, but some resistance immunity, laboratory diagnosis and and culture was carried out in GC medium to vancomycin (33%), oxacillin (66.7%) and control 16th edn. Edinburgh: Churchill on blood agar. Identification, serotyping and erythromycin (66.7%). This is comparable with Livingstone, 1997. susceptibility testing were all performed the Egyptian results,21 although trimethoprim 2 Quagliarello VJ, Scheld WM. Treatment of according to the World Health Organization bacterial meningitis. N Engl J Med 1997; (WHO SOPS-2005) strategy.15 336: 708–16. A total of 59 organisms were isolated ‘Studies suggest that 3 Wenger JD, Hightower AW, Facklam RR, from 284 CSF samples from children with Gaventa S, Broome CV. Bacterial suspected meningitis. Of the 59 organisms current antibiotic regimens meningitis in the United States, 1986: identified, 44 were N. meningitidis, report of a multistate surveillance study. 12 were H. influenzae and just three were in Brazil may not be The Bacterial Meningitis Study Group. S. pneumoniae. Distribution by gender J Infect Dis 1990; 162: 1316–23. showed the following: N. meningitidis (male appropriate for the treatment 4 World Health Organization and the 24, female 20), H. influenzae (male 7, female Centers for Disease Control and 3) and S. pneumoniae (male 2, female 1). of H. influenzae meningitis’ Prevention. Technical guidelines for 894 THE BIOMEDICAL SCIENTIST OCTOBER 2008
  • 3. pp879-885 BMSoct08 17/9/08 15:26 Page 885 ARTICLE 22 Borghouts C, Scheckhuber CQ, Stephan deletion in vivo in normal human skin. 36 Onyango P Celic I, McCaffery JM, Boeke , O, Osiewacz HD. Copper homeostasis J Invest Dermatol 2004; 122: 1277–83. JD, Feinberg AP SIRT3, a human SIR2 . and aging in the fungal model system 29 Brunk UT, Terman A. The mitochondrial- homologue, is an NAD-dependent Podospora anserina: differential lysosomal axis theory of aging: deacetylase localized to mitochondria. expression of PaCtr3 encoding a copper accumulation of damaged mitochondria Proc Natl Acad Sci USA 2002; 99: transporter. Int J Biochem Cell Biol 2002; as a result of imperfect autophagocytosis. 13653–8. 34 (11): 1355–71. Eur J Biochem 2002; 269 (8): 1996–2002. 37 Schwer B, North BJ, Frye RA, Ott M, 23 Brookes PS, Land JM, Clark JB, Heales 30 Guarente L. Mitochondria – a nexus for Verdin E. The human silent information SJR. Peroxynitrite and brain mitochondria: aging, calorie restriction and sirtuins? Cell regulator (Sir)2 homologue hSIRT3 is a evidence for increased proton leak. J 2008; 132 (2): 171–6. mitochondrial nicotinamide adenine Neurochem 1998; 70 (5): 2195–202. 31 Ku HH, Brunk UT, Sohal RS. Relationship dinucleotide-dependent deacetylase. 24 Delaval E, Perichon M, Friguet B. Age- between mitochondrial superoxide and J Cell Biol 2002; 158: 647–57. related impairment of mitochondrial hydrogen peroxide production and 38 Bellizzi D, Rose G, Cavalcante P et al. matrix aconitase and ATP-stimulated longevity of mammalian species. Free Rad A novel VNTR enhancer within the SIRT3 protease in rat liver and heart. Eur J Biol Med 1993; 15 (6): 621–7. gene, a human homologue of SIR2, is Biochem 2004; 271 (22): 4559–64. 32 Barja G, Herrero A. Oxidative damage to associated with survival at oldest ages. 25 de Grey A. Reactive oxygen species mitochiondrial DNA is inversely related Genomics 2005; 85: 258–63. production in the mitochondrial matrix: to maximum life span in the heart and 39 Hallows WC, Lee S, Denu JM. Sirtuins implications for the mechanism of brains of mammals. FASEB J 2000; deacetylate and activate mammalian mitochondrial mutation accumulation. 14: 312–8. acetyl-CoA synthetases. Proc Natl Acad Rejuvenation Res 2005; 8 (1): 13–7. 33 Haigis MC, Guarente LP Mammalian . Sci USA 2006; 103: 10230–5. 26 Kujoth GC, Bradshaw PC, Haroon S, sirtuins – emerging roles in physiology, 40 Schwer B, Bunkenborg J, Verdin RO, Prolla TA. The role of mitochondrial DNA aging, and calorie restriction Genes Dev Andersen JS, Verdin E. Reversible lysine mutations in mammalian aging. PLoS 2006; 20 (21): 2913–21. acetylation controls the activity of the Genet 2007; 3 (2): e24. 34 Civitarese AE, Carling S, Heilbronn LK et mitochondrial enzyme acetyl-CoA 27 Wang Y, Michikawa Y, Mallidis C et al. al. Calorie restriction increases muscle synthetase 2. Proc Natl Acad Sci USA Muscle-specific mutations accumulate mitochondrial biogenesis in healthy 2006; 103: 10224–9. with aging in critical human mtDNA humans. PLoS Med 2007; 4 (3): e76. control sites for replication. Proc Natl Acad 35 Scher MB, Vaquero A, Reinberg D. SirT3 Dr Isabelle Imbert, Anne-Francoise Clay, Joel Sci USA 2001; 98: 4022–7. is a nuclear NAD+-dependent histone Mantelin and Dr Karine Cucumel are 28 Berneburg M, Plettenberg H, Medve-König deacetylase that translocates to the research scientists at Vincience, ISP Global K et al. Induction of the photoaging- mitochondria upon cellular stress. Genes Skin Research Centre, France. associated mitochondrial common Dev 2007; 21: 920–8. BJBS A selection of topics in Volume 65, Number 4, 2008 • Comparative in vitro antimicrobial procedural efficacy for susceptibility of Staphylococcus aureus, Escherichia coli and Pseudomonas species to chloramphenicol, ciprofloxacin and cefaclor • Correlation of Bmi-1 expression and telomerase activity in human ovarian cancer Available online at www.bjbs-online.org • Effect of cytokines on hyaluronan synthase activity and response to oxidative stress by fibroblasts • Molecular characterisation of the recA locus in clinical isolates Reading a of verocytotoxigenic E. coli O157:H7 colleague’s • Cloning and structural analysis of full-length cytolethal distending copy of toxin (cdt) gene operon from Campylobacter lari • Reduction of Staphylococcus epidermidis adhesion to indwelling The Biomedical medical devices: a simple procedure Scientist? • Antibiotic susceptibility patterns of Helicobacter pylori strains from Join the IBMS patients with upper gastrointestinal pathology in western Nigeria and its CPD • Fluorescence (FISH) and chromogenic (CISH) in situ hybridisation in prostate carcinoma cell lines: comparison and use of virtual microscopy scheme • Good analytical practice: statistics and handling data in the biomedical Keep in touch with sciences. A primer and directions for authors. Part 1: Introduction. your profession and Data within and between one or two sets of individuals update your skills OCTOBER 2008 THE BIOMEDICAL SCIENTIST 885